Literature DB >> 1383123

Production and characterization of four anti-neuropeptide Y monoclonal antibodies.

E Grouzmann1, E Comoy, P Walker, M Burnier, C Bohuon, B Waeber, H Brunner.   

Abstract

Human neuropeptide Y (hNPY) is a potent vasoconstrictor peptide of 36 aminoacid residues. We isolated hybridomas secreting four monoclonal antibodies directed against various epitopes of neuropeptide Y and studied their cross-reactivity with peptide YY (PYY) and the pancreatic polypeptide (PP), two peptides sharing sequence homologies with hNPY (respectively 70% and 50%). The antibody NPY02 is an IgG1 with a Ka of 5.5 x 10(10) liters/mol. It binds to the 11-24 region of NPY (IC50 = 2 x 10(-7)M), does not recognize PP but cross-reacts weakly with PYY. Antibodies NPY03 and NPY05 are IgG2 with respective Ka's of 6.7 x 10(9) and 2.5 x 10(10) liters/mol. They interact with a C-terminal epitope on NPY (NPY 27-34, IC50 = 2 x 10(-9) M for NPY03 and NPY 32-36, IC50 = 1 x 10(-9) M for NPY05). These two antibodies cross-react with PYY whereas only NPY05 binds PP. NPY05 is unable to bind the free acid form of neuropeptide Y. The 32-36 COOH free subpeptide is recognized 50,000 less efficiently by NPY05 than its amidated form. Antibody NPY04 is an IgG3 with a Ka of 3.8 x 10(8) liters/mol. It recognizes a N-terminal epitope between aminoacids 1 and 12 (IC50 = 2.5 x 10(-6) M). NPY04 interacts weakly with PYY but not detectably with PP. These results obtained with 4 different monoclonal antibodies demonstrate the presence of at least four epitopes on hNPY, two of them being continuous. These antibodies will be used to study the interaction of NPY with its receptor and to develop sensitive and specific assays for determination of NPY concentrations in biological fluids.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1383123     DOI: 10.1089/hyb.1992.11.409

Source DB:  PubMed          Journal:  Hybridoma        ISSN: 0272-457X


  8 in total

1.  Localization of neuropeptide Y Y1 receptors in cerebral blood vessels.

Authors:  L Bao; J Kopp; X Zhang; Z Q Xu; L F Zhang; H Wong; J Walsh; T Hökfelt
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-11       Impact factor: 11.205

2.  Downregulation of cannabinoid receptor 1 from neuropeptide Y interneurons in the basal ganglia of patients with Huntington's disease and mouse models.

Authors:  Eric A Horne; Jonathan Coy; Katie Swinney; Susan Fung; Allison E T Cherry; William R Marrs; Alipi V Naydenov; Yi Hsing Lin; Xiaocui Sun; C Dirk Keene; Eric Grouzmann; Paul Muchowski; Gillian P Bates; Ken Mackie; Nephi Stella
Journal:  Eur J Neurosci       Date:  2012-11-21       Impact factor: 3.386

3.  Neuropeptide Y secretion from a human insulinoma.

Authors:  G Waeber; J Hurlimann; J A Haefliger; F Gomez; P Nicod; E Grouzmann
Journal:  J Endocrinol Invest       Date:  1996-03       Impact factor: 4.256

4.  The neuropeptide Y/agouti gene-related protein (AGRP) brain circuitry in normal, anorectic, and monosodium glutamate-treated mice.

Authors:  C Broberger; J Johansen; C Johansson; M Schalling; T Hökfelt
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

5.  Neuropeptide Y input to the rat basolateral amygdala complex and modulation by conditioned fear.

Authors:  Randy J Leitermann; Amanda B Rostkowski; Janice H Urban
Journal:  J Comp Neurol       Date:  2016-02-02       Impact factor: 3.215

6.  Differential adenoassociated virus vector-driven expression of a neuropeptide Y gene in primary rat brain astroglial cultures after transfection with Sendai virosomes versus Lipofectin.

Authors:  C M de Fiebre; P Wu; D Notabartolo; W J Millard; E M Meyer
Journal:  Neurochem Res       Date:  1994-06       Impact factor: 3.996

7.  Ultrastructural Correlates of Enhanced Norepinephrine and Neuropeptide Y Cotransmission in the Spontaneously Hypertensive Rat Brain.

Authors:  Ioannis Kourtesis; Sergey Kasparov; Paul Verkade; Anja G Teschemacher
Journal:  ASN Neuro       Date:  2015-10-29       Impact factor: 4.146

8.  DLK1 is a somato-dendritic protein expressed in hypothalamic arginine-vasopressin and oxytocin neurons.

Authors:  Carine Villanueva; Sandrine Jacquier; Nicolas de Roux
Journal:  PLoS One       Date:  2012-04-26       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.